Skip to content

SKIN-LION

Active
Private limited company (pre-2019)founded 2014active for 12 yearsRue de Leuze (Que) 31, 7972 Beloeil, BelgiumKBO/BCE: BE 0556.729.421
Summary

SKIN-LION has been active since 2014 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €151,707 and a net result of €94,522. Equity has been stable since 2019 (±0% per year). Its solvency ranks better than 31% of 20,706 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 18-07-2014 Normal situation
Activity
Specialist medical practice NACE 86220
Establishment unit
2.234.056.686 7972 Beloeil, since 18-07-2014
Financial year end
30 September
Peppol
Reachable since 20-02-2026

Board and ownership

Board
Shareholders
  • Laurence Lionannual accounts 30-09-2017
  • Christelle Lionannual accounts 30-09-2017

Financial position

92 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts to 30-09-2025
Gross margin
€135,943
▲ 9.3%
Turnover
≈ €250,000
estimated
Profit
€94,522
▲ 12.1%
Equity
€151,707
=
Total assets
€397,703
▲ 3.3%
  • 2025 accounts filed 26 days after the deadline
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.57, cash €95,127Size: total assets €397,703Figures for financial year 2025 (filed on 28-05-2026)Show the evidence

Checked score

Score 2025
92 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 37% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 63-1
equity 38.1% of total assets
Liquidity 50+2
short-term debt 57.7% · cash 23.9%
Profitability 98+2
return on assets 23.8%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1%lowest value 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: 0.1%▲ +0.1 percentage points vs 04-2026highest value 06-2026: < 0.1%▼ -0.1 percentage points vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €13,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 1.57 (1.62 in 2024), above the usual 1.5. Short-term debt is 57.7% and cash 23.9% of total assets. However, 61.9% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 31% of them on solvency, 22% on liquidity, 59% on profitability and 37% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 1.57, cash €95,127
NBB · annual accounts
lowers risk · Size: total assets €397,703
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 28-05-2026)
NBB · annual accounts
neutral · A punctual record breaks
This company filed 4 consecutive financial years on time. The year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 26-05-2026, 26 days late. Weigh it accordingly: of the companies that move to filing 1 to 90 days late, 1.41% are now bankrupt, dissolved or in another special legal status, below the 1.66% of all filers. It is a change in behaviour, not evidence of elevated risk.
NBB · 10 filings
Deviation from the deadline
2025
26 days late
2024
5 days early
2023
1 day early
2022
2 days early
2021
25 days early
2019
8 days early
2018
28 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 6 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today. The company usually files around 28 April (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
30-09-2026 year end03-11-2026 today30-04-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Board changedlatest change 30-09-2026 · 1 in office 1 joined · 1 left View
  • Positive: 6 profitable years in a rowprofit 2025: €94,522 6 years View

Recent changes

  1. · Gazette deed Resignation: Nora Coddens (director)
  2. · Gazette deed Appointment: Eva Blanche CODDENS (director)
  3. · Gazette deed Appointment: Nora CODDENS (director)
All 18 events

Comparable companies

These companies have the same main activity as SKIN-LION: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €351,000 and €443,000, founded between 2013 and 2016.

CompanyTotal assetsGross margin
SKIN-LION Beloeil€397,703€135,943
DOCTEUR CHANTAL DEDOBBELEER - CARDIOLOGIE Nivelles€442,899€133,358
Labo Kris Mervillie Nazareth-De Pinte€351,067€140,843
Anesthesie Dr. Frank Van Driessche Antwerpen€352,007€143,152
SCSPRL DOCTEUR LAETITIA BRASSINNE Brussel€427,415€143,071
KEAS Brussel€409,443€122,360
Dr. Robert Oonk, urgentiearts – anesthesist Mechelen€392,871€142,762
Full comparison

Key facts about SKIN-LION

What is the company number of SKIN-LION?
The company number of SKIN-LION is 0556.729.421. The VAT number is the same number with BE in front: BE 0556.729.421.
Where is SKIN-LION based?
The registered office is at Rue de Leuze (Que) 31, 7972 Beloeil.Company details
What does SKIN-LION do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of SKIN-LION?
The legal form of SKIN-LION is Private limited company (pre-2019) (BVBA).
When was SKIN-LION founded?
SKIN-LION was founded on 18-07-2014.
Is SKIN-LION still active?
Yes, SKIN-LION is an active enterprise in the KBO register.
What is the turnover of SKIN-LION?
The turnover in financial year 2025 is ≈ €250,000. This figure is estimated from the gross margin of €135,943 and 42 comparable companies (NACE 86220). It probably lies between €210,000 and €330,000.Financials
Is SKIN-LION profitable?
In financial year 2025, SKIN-LION made a profit of €94,522.
Where can I find the annual accounts of SKIN-LION?
SKIN-LION filed 10 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of SKIN-LION due?
SKIN-LION must file the annual accounts for financial year 2026 by 30-04-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.